Eikon Therapeutics, Inc. (EIKN) News
Follow Eikon Therapeutics, Inc. (EIKN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Eikon Therapeutics appoints Ching-Pin Chang as EV P and CSO
Eikon Therapeutics announced the appointment of Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer.
EQUITY | Sep 03, 2026, 11:38 AM UTC
L
Eikon Therapeutics appoints Ching-Pin Chang as EVP and CSO
Eikon Therapeutics appointed Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer.
EQUITY | Sep 03, 2026, 11:30 AM UTC
L
Eikon Therapeutics to participate in investor conferences in September 2026
Eikon Therapeutics said it will participate in investor conferences during September 2026.
EQUITY | Aug 26, 2026, 11:30 AM UTC
L
Eikon Therapeutics to Participate in Cantor KOL PARP-Inhibitor Event
Eikon Therapeutics (EIKN) says it will participate in a KOL event on the therapeutic use of PARP inhibitors in oncology hosted by Cantor Fitzgerald.
EQUITY | Aug 18, 2026, 08:15 PM UTC
L
Eikon Therapeutics reports Q2 2026 results and clinical updates
Eikon Therapeutics (EIKN) reports second quarter 2026 financial results and provides clinical updates, according to a TradeXchange Newsdesk release.
EARNINGS | Aug 13, 2026, 08:02 PM UTC
L
EIKN shares rise 10% after the company dosed the first patient in a key registrational trial for its first-line therapy lung cancer treatmen
EIKN shares rise 10% after the company dosed the first patient in a key registrational trial for its first-line therapy lung cancer treatment.
EQUITY | Jul 27, 2026, 02:24 PM UTC
M
12 Health Care Stocks Move
Twelve health care stocks are moving in Thursday's after-market session, with Shuttle Pharmaceuticals and INVO Fertility among the gainers and Creative Medical Tech and Catheter Precision among the losers
EQUITY | Jun 25, 2026, 09:05 PM UTC
L
EIKN Joins Russell 3000
Eikon Therapeutics to join the Russell 3000 Index, reflecting progress as a publicly traded company
EQUITY | Jun 25, 2026, 08:15 PM UTC